Search clinical trials for: surufatinib fulvestrant chidamide
Total 715 results
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Sichuan UniversityUnknownMDS | Leukemia, AcuteChina
-
Shengjing HospitalRecruiting
-
Peng LiuChipscreen Biosciences, Ltd.Unknown
-
Sichuan UniversityUnknown
-
The First Affiliated Hospital of Soochow UniversityRecruitingDiffuse Large B-Cell LymphomaChina
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland, South Africa
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
Eisai Co., Ltd.Active, not recruiting
-
Nancy Chan, MDMerck Sharp & Dohme LLCActive, not recruiting
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Syndax PharmaceuticalsWithdrawn
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
Cancer Institute and Hospital, Chinese Academy...OrigiMedUnknown
-
University of Southern CaliforniaAstraZenecaTerminatedBreast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Icahn School of Medicine at Mount SinaiAstraZenecaTerminated
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Chinese PLA General HospitalThe General Hospital of Western Theater Command; First Hospital of China Medical... and other collaboratorsRecruitingAcute Myeloid LeukemiaChina
-
Loma Linda UniversityWithdrawnLaryngopharyngeal Reflux | Eustachian Tube DysfunctionUnited States
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingAdvanced Breast CancerUnited Kingdom
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
University of Kansas Medical CenterAstraZenecaCompletedInvasive Breast CancerUnited States
-
Washington University School of MedicineUnited States Department of Defense; Puma Biotechnology, Inc.CompletedBreast NeoplasmsUnited States, Canada
-
Mothaffar RimawiAstraZenecaCompletedBreast CancerUnited States
-
Fudan UniversityWithdrawnCarcinoma Breast Stage IV
-
AstraZenecaCompletedBreast Cancer | MetastasisUnited States, Australia, Brazil, France, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Poland, Japan, Argentina, Austria, Canada, Hungary, Israel, Netherlands, New Zealand, Portugal, Taiwan, Germany, Finlan... and more
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated
-
Calithera Biosciences, IncCompleted
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
Hospital Affiliated to Military Medical Science...UnknownMetastatic Breast CancerChina
-
Chinese PLA General HospitalRecruiting
-
Beijing Friendship HospitalRecruitingHemophagocytic Lymphohistiocytosis | ChidamideChina
-
Mingzhi ZhangUnknownPeripheral T-cell LymphomaChina
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
University of PittsburghTerminatedNon-small Cell Lung Cancer | Postmenopausal WomenUnited States
-
Eli Lilly and CompanyRecruitingBreast Neoplasms | Neoplasm MetastasisJapan, United States, China, Czechia, Belgium, Brazil, Germany, Netherlands, Russian Federation, Ukraine, Taiwan, France, Korea, Republic of, Italy, Spain, Australia, Turkey, India, Argentina, Greece, Austria, Mexico